226 related articles for article (PubMed ID: 34836657)
1. Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy.
Huntoon K; Damante M; Wang J; Olencki T; Elder JB
Curr Probl Cancer; 2022 Apr; 46(2):100805. PubMed ID: 34836657
[TBL] [Abstract][Full Text] [Related]
2. Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.
Damante M; Huntoon K; Gibbs D; Pezzutti D; Olencki T; Elder JB
Neurosurg Focus; 2023 Aug; 55(2):E2. PubMed ID: 37527670
[TBL] [Abstract][Full Text] [Related]
3. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
J Neurooncol; 2016 Oct; 130(1):221-228. PubMed ID: 27538910
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis.
Bastos DA; Molina AM; Hatzoglou V; Jia X; Velasco S; Patil S; Voss MH; Feldman DR; Motzer RJ
Clin Genitourin Cancer; 2015 Feb; 13(1):59-66. PubMed ID: 25023939
[TBL] [Abstract][Full Text] [Related]
5. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
6. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
Vogl UM; Bojic M; Lamm W; Frischer JM; Pichelmayer O; Kramer G; Haitel A; Kitz K; Harmankaya K; Zielinski CC; Schmidinger M
BMC Cancer; 2010 Sep; 10():480. PubMed ID: 20819239
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of brain metastasis of renal cell carcinoma.
Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.
Bates JE; Youn P; Peterson CR; Usuki KY; Walter KA; Okunieff P; Milano MT
Am J Clin Oncol; 2017 Oct; 40(5):439-443. PubMed ID: 25730604
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
11. Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.
Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Tanabe K
Jpn J Clin Oncol; 2021 Apr; 51(5):793-801. PubMed ID: 33324983
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients.
Klausner G; Troussier I; Biau J; Jacob J; Schernberg A; Canova CH; Simon JM; Borius PY; Malouf G; Spano JP; Roupret M; Cornu P; Mazeron JJ; Valéry C; Feuvret L; Maingon P
Clin Genitourin Cancer; 2019 Jun; 17(3):191-200. PubMed ID: 30926219
[TBL] [Abstract][Full Text] [Related]
13. Global management of brain metastasis from renal cell carcinoma.
Pierrard J; Tison T; Grisay G; Seront E
Crit Rev Oncol Hematol; 2022 Mar; 171():103600. PubMed ID: 35063636
[TBL] [Abstract][Full Text] [Related]
14. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
[TBL] [Abstract][Full Text] [Related]
15. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study.
Internò V; Massari F; Rudà R; Maiorano BA; Caffo O; Procopio G; Bracarda S; Atzori F; Passarelli A; Bersanelli M; Stellato M; Fornarini G; Galli L; Ortega C; Zanardi E; Incorvaia L; Facchini G; Giron Berrios JR; Ricotta R; Santoni M; Funaioli C; Trerotoli P; Porta C; Rizzo M
ESMO Open; 2023 Aug; 8(4):101598. PubMed ID: 37467658
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin.
Kattan J; Rassy EE; Assi T; Bakouny Z; Pavlidis N
Crit Rev Oncol Hematol; 2018 Oct; 130():60-69. PubMed ID: 30196913
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.
Vickers MM; Al-Harbi H; Choueiri TK; Kollmannsberger C; North S; MacKenzie M; Knox JJ; Rini BI; Heng DY
Clin Genitourin Cancer; 2013 Sep; 11(3):311-5. PubMed ID: 23684422
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
Wroński M; Arbit E; Russo P; Galicich JH
Urology; 1996 Feb; 47(2):187-93. PubMed ID: 8607231
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.
Di Franco G; Gianardi D; Palmeri M; Furbetta N; Guadagni S; Bianchini M; Bonari F; Sbrana A; Vasile E; Pollina LE; Mosca F; Di Candio G; Morelli L
Eur J Surg Oncol; 2020 May; 46(5):825-831. PubMed ID: 31806518
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy.
Hara H; Kawamoto T; Fukase N; Sawada R; Fujiwara S; Yahiro S; Miyamoto T; Terakawa T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
Eur J Surg Oncol; 2023 May; 49(5):928-933. PubMed ID: 36463006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]